Consistent with prior studies, our findings corroborate the association between elevated IL-6 levels and adverse clinical outcomes, including prolonged hospital stays, complications, and mortality among COVID-19 patients [35,36,37,38]. This evidence concerns the gene IL6 and COVID-19.